FTRE
Fortrea Holdings Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$889.18M
P/E Ratio
—
EPS
$-10.81
Beta
1.77
52W High
$18.67
52W Low
$3.97
50-Day MA
$11.47
200-Day MA
$10.67
Dividend Yield
—
Profit Margin
-36.20%
Forward P/E
5.49
PEG Ratio
0.34
About Fortrea Holdings Inc.
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $2.72B |
| Gross Profit (TTM) | $503.80M |
| EBITDA | $41.50M |
| Operating Margin | 1.33% |
| Return on Equity | -102.40% |
| Return on Assets | -0.61% |
| Revenue/Share (TTM) | $29.86 |
| Book Value | $6.05 |
| Price-to-Book | 1.57 |
| Price-to-Sales (TTM) | 0.33 |
| EV/Revenue | 0.67 |
| EV/EBITDA | 92.35 |
| Quarterly Earnings Growth (YoY) | -57.40% |
| Quarterly Revenue Growth (YoY) | -5.20% |
| Shares Outstanding | $93.50M |
| Float | $92.93M |
| % Insiders | 0.58% |
| % Institutions | 103.89% |
Analyst Ratings
Consensus ($14.21 target)
1
Strong Buy4
Buy6
Hold1
Strong SellData last updated: 4/8/2026